Table 2.
Logistic regression analysis between ALDH2 and clinical properties of HNSC.
| Characteristics | Total(N) | Odds ratio (OR) | P value |
|---|---|---|---|
| T stage (T3 & T4 vs T1 & T2) | 485 | 0.672 (0.462-0.974) | .037 |
| N stage (N1 & N2 & N3 vs N0) | 478 | 0.691 (0.481-0.990) | .044 |
| M stage (M1 vs M0) | 475 | 1.475 (0.242-11.272) | .672 |
| Clinical stage (Stage III & Stage IV vs Stage I & Stage II) | 486 | 0.714 (0.466-1.088) | .119 |
| Gender (Male vs Female) | 500 | 0.866 (0.582-1.288) | .479 |
| Age (>60 vs ⩽60) | 499 | 1.058 (0.745-1.503) | .753 |
| Histologic grade (G3 & G4 vs G1 & G2) | 481 | 1.161 (0.769-1.756) | .478 |
| Alcohol history (Yes vs No) | 489 | 0.722 (0.492-1.056) | .094 |
| Smoker (Yes vs No) | 490 | 0.858 (0.561-1.311) | .480 |
| Lymphovascular invasion (Yes vs No) | 339 | 1.066 (0.683-1.665) | .778 |
| Radiation therapy (Yes vs No) | 439 | 0.975 (0.658-1.444) | .900 |
| Lymphnode neck dissection (Yes vs No) | 497 | 0.952 (0.602-1.504) | .832 |